CASE STUDY: Delivering Flexibility in a Multi-site Global Harmonized Clinical Trial
Eurofins Bioanalytical Services cross-validated a PK assay and three PD biomarker assays for a global trial involving pediatric patients with a rare inflammatory syndrome. The study used a monoclonal antibody biotherapeutic, with near real-time PK and PD data essential for understanding disease evolution during treatment.